The risk of primary and contralateral breast cancer after ovarian cancer inBRCA1/BRCA2mutation carriers-Reference-Cited by-同舟云学术

The risk of primary and contralateral breast cancer after ovarian cancer inBRCA1/BRCA2mutation carriers

Published:2012-11-16 Issue:5 Volume:119 Page:955-962
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vencken Peggy M. L. H.,Kriege Mieke,Hooning Maartje,Menke-Pluymers Marian B.,Heemskerk-Gerritsen Bernadette A. M.,van Doorn Lena C.,Collée Margriet M.,Jager Agnes,van Montfort Cees,Burger Curt W.,Seynaeve Caroline

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27839/fullpdf

Reference42 articles.

1. Penetrance of breast cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age;Van der Kolk;Breast Cancer Res Treat.,2010

2. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium;Ford;Am J Hum Genet.,1998

3. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J Clin Oncol.,2007

4. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers;Rebbeck;J Natl Cancer Inst.,1999

5. Common breast cancer susceptibility alleles and the risk of BC for BRCA1 and BRCA2 mutation carriers: implications for risk prediction;Antoniou;Cancer Res.,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy;Genetics in Medicine;2024-09

2. Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report;Hereditary Cancer in Clinical Practice;2024-02-15

3. Counselling Framework for Germline BRCA1/2 and PALB2 Carriers Considering Risk-Reducing Mastectomy;Current Oncology;2024-01-09

4. PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer;Journal of Gynecologic Oncology;2024

5. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study;Frontiers in Oncology;2023-09-14